Almirall, S.A. (LON: 0O9B)

London flag London · Delayed Price · Currency is GBP · Price in EUR
8.54
-0.17 (-1.90%)
At close: Jan 21, 2025
0.06%
Market Cap 1.53B
Revenue (ttm) 793.44M
Net Income (ttm) -37.34M
Shares Out n/a
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date May 17, 2024
Volume 694
Average Volume 2,809
Open 8.60
Previous Close 8.71
Day's Range 8.46 - 8.68
52-Week Range 6.43 - 8.26
Beta 0.36
RSI 51.77
Earnings Date Feb 24, 2025

About Almirall

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musc... [Read more]

Industry Pharmaceutical Preparations
Founded 1943
Employees 1,904
Stock Exchange London Stock Exchange
Ticker Symbol 0O9B
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.